Latest | F'cast | |
---|---|---|
Div Yield | 1.7% | 0.0% |
Div Cover | 1.4 | 2.0 |
Op Mrgn | -5.2% | 8.7% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | 42.1 | 31.5 |
PEG | n/a | 38.9 |
Pr/Revenue | 2.1 | 1.4 |
Pr/Book | 3.2 |
Latest | F'cast | |
---|---|---|
Revenue | -7.5% | -14.3% |
PBT | n/a | n/a |
EPS | -26.3% | 1.6% |
DPS | -34.1% | -44.9% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-19 | 128.40 | 8.70 | 67.20p | 24.7 | n/a | -13% | 20.83p | 1.3% |
30-Sep-20 | 213.60 | 2.20 | 98.60¢ | 55.5 | 4.0 | +14% | 34.50¢ | 0.6% |
30-Sep-21 | 248.30 | (35.60) | 60.60¢ | 41.2 | n/a | -38% | 44.90¢ | 1.8% |
30-Sep-22 | 263.50 | 6.00 | 54.70¢ | 26.4 | n/a | -10% | 44.90¢ | 3.1% |
30-Sep-23 | 243.80 | (20.20) | 40.30¢ | 19.7 | n/a | -26% | 29.60¢ | 3.7% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-24 | 268.83 | 23.44 | 40.94p | 32.1 | 20.2 | +2% | 20.97p | 0.0% |
30-Sep-25 | 284.98 | 29.71 | 51.46p | 25.6 | 1.0 | +26% | 22.90p | 0.0% |
30-Sep-26 | 306.05 | 43.64 | 78.02p | 16.9 | 0.3 | +52% | 26.82p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
New delivery order & updated FY 2024 guidance | 25-Jul-2024 | 07:00 | RNS |
Notification of transaction of PDMR | 10-Jul-2024 | 09:00 | RNS |
Directors'/PDMR Shareholdings | 08-Jul-2024 | 12:00 | RNS |
Drug film probe | 22-Apr-2008 | Sun |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
09-Jul-24 | Buy | Maggie Brereton | 1,278.00p | 1,565 | £20,000.70 |
05-Jul-24 | Buy | Jos Sclater | 1,283.00p | 12 | £153.96 |
05-Jul-24 | Buy | Rich Cashin | 1,283.00p | 12 | £153.96 |
Currency | UK Pounds |
Share Price | 1,340.00p |
Change Today | 24.00p |
% Change | 1.82 % |
52 Week High | 1,378.00 |
52 Week Low | 593.00 |
Volume | 29,549 |
Shares Issued | 30.26m |
Market Cap | £405.46m |
RiskGrade | 186 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 08-Aug-24 | 08-Feb-24 |
Paid | 06-Sep-24 | 08-Mar-24 |
Amount | 7.20¢ | 15.30¢ |
Time | Volume / Share Price |
16:35 | 7,970 @ 1,340.00p |
16:35 | 33 @ 1,340.00p |
16:35 | 22 @ 1,340.00p |
16:35 | 11 @ 1,340.00p |
16:35 | 83 @ 1,340.00p |
You are here: research